Skip to content

Clinical trials

Myeloproliferative Disorders trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Hungary Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20132
20144
20151
20191
20202
20214
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting5
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AOP Orphan Pharmaceuticals AG2
CTI BioPharma2
Celgene2
Incyte Corporation2
Geron Corporation1
Karyopharm Therapeutics Inc1
Sierra Oncology LLC - a GSK company1
Terumo BCT1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders16
Primary Myelofibrosis8
Bone Marrow Diseases7
Hematologic Diseases7
Polycythemia Vera5
Anemia4
Polycythemia3
Thrombocytopenia3
Leukemia2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.